Armistice Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

A detailed history of Armistice Capital, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 8,200,000 shares of AUPH stock, worth $73.6 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

8,200,000

Previous 11,136,000 26.36%

Holding current value

$73.6 Million

Previous $63.6 Million 5.47%

% of portfolio

1.0%

Previous 0.83%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.32 - $7.33 $15.6 Million - $21.5 Million	-2,936,000 Reduced 26.36%	8,200,000 $60.1 Million
Q2 2024 Aug 14, 2024	SELL	$4.81 - $5.78 $5.41 Million - $6.5 Million	-1,124,000 Reduced 9.17%	11,136,000 $63.6 Million
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $13.4 Million - $25.4 Million	2,724,000 Added 28.57%	12,260,000 $61.4 Million
Q4 2023 Feb 13, 2024	BUY	$7.13 - $9.49 $24.9 Million - $33.1 Million	3,488,000 Added 57.67%	9,536,000 $85.7 Million
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $10.5 Million - $16.6 Million	1,356,000 Added 28.9%	6,048,000 $47 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $4.66 Million - $6.08 Million	520,000 Added 12.46%	4,692,000 $45.4 Million
Q1 2023 May 15, 2023	SELL	$5.94 - $11.27 $4.92 Million - $9.33 Million	-828,000 Reduced 16.56%	4,172,000 $45.7 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $17.6 Million - $34.8 Million	4,276,000 Added 590.61%	5,000,000 $21.6 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $4.82 Million - $8.97 Million	724,000 New	724,000 $5.44 Million
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $6.47 Million - $8.03 Million	-500,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $6.6 Million - $8.33 Million	500,000 New	500,000 $7.37 Million

Others Institutions Holding AUPH

# of Institutions

207

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.27B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History